Lucentis [ranibizumab] in the treatment of macular edema - a phase II, single center, randomized study to evaluate the efficacy of ranibizumab versus focal laser treatment in subjects with diabetic macular edema.
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 23 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 May 2012 Actual end date Feb 2009 added as reported by ClinicalTrials.gov.
- 09 Nov 2008 Actual patient number 49 added as reported by ClinicalTrials.gov.